UBS’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2014
Q3
$51K Sell
9,744
-1,408
-13% -$7.37K ﹤0.01% 4635
2014
Q2
$48K Buy
11,152
+8,502
+321% +$36.6K ﹤0.01% 4672
2014
Q1
$11K Sell
2,650
-2,818
-52% -$11.7K ﹤0.01% 5614
2013
Q4
$29K Sell
5,468
-7,360
-57% -$39K ﹤0.01% 4957
2013
Q3
$65K Buy
12,828
+11,078
+633% +$56.1K ﹤0.01% 4224
2013
Q2
$8K Buy
+1,750
New +$8K ﹤0.01% 5458